Clinical Trial: Tocilizumab for Relapsing Polychondritis
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: Efficacy of Tocilizumab in a Patient With Relapsing Polychondritis
Brief Summary: This is a study for one patient with severe relapsing polychondritis which has been unresponsive to other more conventional medications including prednisone, methotrexate, anakinra and TNF inhibitors. Tolerability, and efficacy of the drug, Tocilizumab will be monitored by clinical assessment and bloodwork.
Detailed Summary:
Sponsor: McMaster Children's Hospital
Current Primary Outcome: Efficacy of Tocilizumab [ Time Frame: 2 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Safety of Tocilizumab [ Time Frame: 2 years ]
Original Secondary Outcome: Same as current
Information By: McMaster Children's Hospital
Dates:
Date Received: April 13, 2010
Date Started: May 2010
Date Completion: May 2012
Last Updated: May 12, 2014
Last Verified: May 2014